Supplementary Fig. S1 from Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

Cristiana Sessa,Patricia Lorusso,Anthony Tolcher,Françoise Farace,Nathalie Lassau,Angelo Delmonte, Antonio Braghetti,Rastislav Bahleda,Patrick Cohen,Marie Hospitel,Christine Veyrat-Follet,Jean-Charles Soria

crossref（2023）

引用 0|浏览3

暂无评分

摘要

Supplementary Fig. S1 - PDF file 83K, Time profiles for estimated change relative to baseline in (A) heart rate and (B) Fridericia-corrected QT interval

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要